Valuation guide

2026 Healthcare and Home Care Valuation Multiples

Most home care, home health, hospice, and related healthcare-services businesses are valued from normalized SDE or adjusted EBITDA, then adjusted for payer mix, census or client stability, staff retention, referral concentration, compliance history, owner dependence, margins, growth, and buyer fit.

Home care valuationHome health multiplesHospice valuationSDE and EBITDA

Short answer: smaller owner-operated home care agencies often trade on SDE, while larger home health, hospice, and platform-quality healthcare-services companies usually trade on adjusted EBITDA. The multiple range depends less on revenue alone and more on earnings quality, transferability, compliance risk, payer mix, and buyer demand.

2026 Planning Ranges by Agency Type

The ranges below are planning ranges, not promised sale prices. A buyer will still normalize earnings, test revenue quality, review compliance, evaluate management depth, and discount risks that make cash flow harder to transfer after closing.

Business TypeTypical BasisPlanning RangeWhat Moves the Range
Private duty / non-medical home careSDE for smaller agencies; EBITDA for scaled agencies2.5x-4.0x SDE; higher for larger, manager-led platformsCaregiver retention, recurring hours, client concentration, private-pay vs Medicaid mix, referral sources, owner dependence.
Medicare-certified home healthAdjusted EBITDA4.0x-8.0x EBITDAClinical census quality, skilled nursing and therapy mix, payer mix, survey history, referral sources, CHOW planning, management depth.
Hospice agencyAdjusted EBITDA6.0x-9.0x EBITDAADC and census trend, cap exposure, referral concentration, clinical leadership, compliance history, patient/family sensitivity, buyer fit.
Combined home health and hospiceAdjusted EBITDA7.0x-10.0x EBITDAContinuum-of-care value, scale, clean compliance across both lines, integration quality, leadership depth, payer stability.
Home care franchise resaleSDE or EBITDA depending scale2.5x-4.5x SDE for many owner-operated resalesFranchisor approval, transfer fees, royalty load, territory rights, renewal terms, local office performance, buyer qualifications.
Healthcare RCM / medical billingSDE or adjusted EBITDA3.5x-7.0x EBITDA for stronger recurring-revenue companiesClient retention, recurring contract revenue, AR performance, denial management, specialty mix, compliance, systems, staff depth.

Do not use a table multiple as a substitute for valuation. A clean $1 million EBITDA agency can be more valuable than a larger agency with weak margins, compliance exposure, declining census, or concentrated referrals.

SDE vs. EBITDA: Which Number Matters?

Small agencies usually trade on seller’s discretionary earnings because the owner is still part of the operating model. Buyers look at the cash flow available to one owner-operator after normalizing personal, one-time, and discretionary expenses.

Larger agencies usually trade on adjusted EBITDA because buyers expect a management layer, cleaner financial controls, and transferable operations. EBITDA buyers care less about replacing the owner’s job and more about whether the business can run under new ownership.

SDE-driven valuation

Common for smaller private duty, franchise resale, and owner-led agencies where the owner still manages referrals, scheduling, staffing, or finance.

EBITDA-driven valuation

Common for larger home health, hospice, RCM, and platform-quality agencies with management depth and cleaner operating systems.

What Increases a Home Care Agency’s Value?

Buyers pay more when the earnings appear durable after the seller exits. The strongest agencies usually have clean financials, stable staff, recurring client or census patterns, diverse referral sources, defensible margins, and a management team that can stay through transition.

  • Defensible add-backs and clean monthly financial statements.
  • Stable or growing census, hours, visits, or recurring client revenue.
  • Low owner dependence and a second layer of managers or clinical leaders.
  • Diverse referral sources rather than one dominant hospital, physician group, family, facility, or marketer.
  • Clean compliance, survey, billing, payroll, and documentation history.
  • Payer mix that supports margin quality and reduces reimbursement concentration.

What Lowers the Multiple?

Multiple discounts usually come from transfer risk. If a buyer thinks earnings may disappear after closing, the offer will reflect that risk.

Owner dependence

The owner controls referrals, client relationships, scheduling, billing, hiring, or clinical leadership with no clear replacement.

Concentration risk

Too much revenue comes from one referral source, one payer, one large client, one facility, or one contract.

Compliance or billing risk

Survey issues, documentation gaps, billing errors, HIPAA issues, or unsupported add-backs create diligence drag.

Weak staff continuity

High caregiver, clinician, biller, or manager turnover makes the business harder to transfer.

Why Home Health and Hospice Get Extra Diligence

Medicare-certified home health and hospice agencies can command stronger buyer interest, but they also attract deeper diligence. Buyers review CHOW or licensure planning, survey history, referral patterns, clinical leadership, documentation quality, cap exposure in hospice, payer mix, and compliance posture.

CMS has also increased scrutiny of hospice and home health enrollment and ownership transparency, which makes diligence quality more important for regulated agencies. That does not mean a clean agency cannot sell; it means buyers will look harder before assigning a premium multiple.

What Buyers Request Before Making an Offer

Document or DataWhy It Matters
Monthly P&Ls, balance sheets, and tax returnsUsed to normalize SDE or EBITDA and test earnings consistency.
Payer revenue detailShows private pay, Medicaid, Medicare, commercial, managed care, VA, or other exposure.
Census, visits, care hours, or client trendsShows stability, seasonality, concentration, and whether growth is durable.
Payroll, staff roster, and retention dataShows caregiver, clinician, manager, biller, and administrative continuity.
Referral source detailShows concentration risk and whether revenue is transferable.
Licenses, surveys, contracts, and compliance recordsShows operating risk, renewal risk, CHOW/licensure issues, and diligence readiness.

Use Multiples as a Starting Point, Not the Answer

A multiple is only useful after the earnings number is right. A buyer may agree that an agency belongs in a strong market category, then reduce value after reviewing add-backs, payer mix, referral concentration, caregiver turnover, compliance history, or owner dependence.

If you are considering a sale, the better first step is a confidential valuation that reviews your actual financials, payer mix, staffing, referrals, compliance, and readiness.

Sources and Context Used

This guide combines Home Care Business Broker’s buyer-facing valuation framework with public regulatory and market context. Useful public context includes CMS ownership transparency for Medicare-certified home health and hospice agencies, CMS hospice utilization reporting, and CMS’s 2026 enrollment moratoria announcement for hospice and home health agencies.

Frequently Asked Questions

What multiple do home care agencies sell for?

Many smaller owner-operated home care agencies are valued around an SDE multiple, often in the 2.5x-4.0x SDE planning range. Larger, manager-led agencies with stronger margins, cleaner financials, payer diversity, and lower owner dependence may be evaluated on adjusted EBITDA instead.

Are hospice agencies worth more than private duty home care agencies?

Hospice agencies can command higher EBITDA multiples when census, compliance, clinical leadership, referral sources, and cap exposure are clean. Hospice agencies with survey issues, aggressive admissions patterns, referral concentration, or weak leadership can be discounted heavily.

How do buyers value a home health agency?

Buyers usually start with adjusted EBITDA, then review Medicare certification, clinical census quality, skilled nursing and therapy mix, payer mix, survey history, referral sources, CHOW planning, owner dependence, and management depth.

Should I use revenue to value my agency?

Revenue alone is not enough. Two agencies with the same revenue can be worth very different amounts if one has stronger margins, cleaner compliance, better staff retention, lower owner dependence, and more transferable referral sources.

When should I request a valuation?

Request a valuation before you need to sell. Early review gives an owner time to clean financials, document add-backs, reduce owner dependence, diversify referrals, improve staffing, and address diligence issues before going to market.

Private valuation

Find Out What Your Agency May Be Worth

Get a confidential review of value, buyer fit, readiness, and diligence issues before deciding whether to sell.